Top Penny Stocks To Add to Your Watchlist - November 16th

Key Points

• MarketBeat flags five penny stocks to watch — Leap Therapeutics (LPTX), Cypherpunk Technologies (CYPH), Invivyd (IVVD), Bitfarms (BITF) and Beyond Meat (BYND) — which recently had the highest dollar trading volume among penny stocks.
• Penny stocks are typically shares trading under $5 (often under $1) and are usually thinly traded on OTC or smaller exchanges, meaning they carry low liquidity, high volatility and greater risk of large price swings, manipulation, or fraud.
• The group spans different themes — mainly biotech (LPTX, CYPH, IVVD), cryptocurrency mining (BITF) and plant-based food (BYND) — offering varied exposure but remaining highly speculative.

Leap Therapeutics, Cypherpunk Technologies, Invivyd, Bitfarms, and Beyond Meat are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small, often thinly traded companies—commonly defined as securities trading for less than $5 per share (and frequently under $1) and often quoted on over-the-counter markets or lesser-known exchanges. They tend to have low liquidity and high volatility, making them highly speculative and carrying greater risk of large price swings, manipulation, or fraud. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Leap Therapeutics (LPTX)

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers.

Read Our Latest Research Report on LPTX

Cypherpunk Technologies (CYPH)

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501.

Read Our Latest Research Report on CYPH

Invivyd (IVVD)

Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.

Read Our Latest Research Report on IVVD

Bitfarms (BITF)

Bitfarms Ltd. engages in the mining of cryptocurrency coins and tokens in Canada, the United States, Paraguay, and Argentina. It owns and operates server farms that primarily validates transactions on the Bitcoin Blockchain and earning cryptocurrency from block rewards and transaction fees. The company also provides electrician services to commercial and residential customers in Quebec, Canada.

Read Our Latest Research Report on BITF

Beyond Meat (BYND)

Beyond Meat, Inc., a plant-based meat company, develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club stores, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools.

Read Our Latest Research Report on BYND